Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Neoplasms | 10 | 2015 | 22 | 2.760 |
Why?
|
| Spinal Cord Neoplasms | 6 | 2013 | 12 | 2.320 |
Why?
|
| Fetal Proteins | 4 | 2016 | 7 | 1.980 |
Why?
|
| T-Box Domain Proteins | 4 | 2016 | 14 | 1.970 |
Why?
|
| Chordoma | 6 | 2016 | 7 | 1.950 |
Why?
|
| Neurosurgical Procedures | 8 | 2018 | 99 | 1.440 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2016 | 10 | 1.030 |
Why?
|
| Thoracic Vertebrae | 3 | 2015 | 42 | 0.900 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2015 | 69 | 0.740 |
Why?
|
| Humans | 46 | 2020 | 32005 | 0.730 |
Why?
|
| Back Pain | 1 | 2020 | 28 | 0.720 |
Why?
|
| Atlanto-Occipital Joint | 2 | 2010 | 4 | 0.720 |
Why?
|
| Cannabinoids | 1 | 2020 | 41 | 0.700 |
Why?
|
| Stereotaxic Techniques | 3 | 2010 | 23 | 0.690 |
Why?
|
| Cervical Vertebrae | 4 | 2015 | 44 | 0.690 |
Why?
|
| Cell Line, Tumor | 5 | 2016 | 726 | 0.670 |
Why?
|
| Spinal Fusion | 5 | 2014 | 41 | 0.660 |
Why?
|
| Preoperative Care | 2 | 2011 | 114 | 0.650 |
Why?
|
| Lumbar Vertebrae | 4 | 2019 | 101 | 0.650 |
Why?
|
| Brain Abscess | 1 | 2018 | 4 | 0.630 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2018 | 6 | 0.630 |
Why?
|
| Cell Proliferation | 3 | 2016 | 604 | 0.620 |
Why?
|
| Hearing Aids | 1 | 2017 | 4 | 0.610 |
Why?
|
| Decompression, Surgical | 3 | 2019 | 55 | 0.610 |
Why?
|
| Meningitis, Fungal | 1 | 2017 | 1 | 0.580 |
Why?
|
| Ascomycota | 1 | 2017 | 4 | 0.580 |
Why?
|
| Methylprednisolone | 1 | 2017 | 12 | 0.580 |
Why?
|
| Drug Contamination | 1 | 2017 | 6 | 0.570 |
Why?
|
| Abscess | 1 | 2017 | 26 | 0.570 |
Why?
|
| Liposomes | 1 | 2016 | 27 | 0.560 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 57 | 0.540 |
Why?
|
| Communication | 1 | 2017 | 142 | 0.540 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 114 | 0.540 |
Why?
|
| Nanoparticles | 1 | 2016 | 52 | 0.530 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 240 | 0.520 |
Why?
|
| Monitoring, Intraoperative | 4 | 2009 | 42 | 0.520 |
Why?
|
| Chondrosarcoma | 2 | 2014 | 7 | 0.500 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2015 | 2 | 0.500 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 85 | 0.470 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2014 | 4 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 36 | 0.460 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 43 | 0.460 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 4 | 0.460 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2014 | 53 | 0.460 |
Why?
|
| Intraoperative Complications | 2 | 2011 | 56 | 0.450 |
Why?
|
| Atlanto-Axial Joint | 2 | 2010 | 4 | 0.450 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2010 | 26 | 0.440 |
Why?
|
| Endoscopy | 2 | 2010 | 58 | 0.430 |
Why?
|
| Vasospasm, Intracranial | 2 | 2010 | 13 | 0.430 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 412 | 0.420 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 154 | 0.400 |
Why?
|
| Apoptosis | 1 | 2014 | 360 | 0.400 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 99 | 0.390 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2011 | 1 | 0.390 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 1022 | 0.390 |
Why?
|
| Medical Errors | 1 | 2011 | 36 | 0.380 |
Why?
|
| Male | 21 | 2019 | 19165 | 0.370 |
Why?
|
| Basilar Artery | 1 | 2010 | 9 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2014 | 918 | 0.370 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2010 | 7 | 0.370 |
Why?
|
| Spinal Cord Compression | 1 | 2010 | 7 | 0.360 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 89 | 0.360 |
Why?
|
| Cervical Atlas | 1 | 2010 | 1 | 0.360 |
Why?
|
| Skull Base | 1 | 2010 | 4 | 0.360 |
Why?
|
| Laminectomy | 3 | 2019 | 16 | 0.360 |
Why?
|
| Radiosurgery | 2 | 2011 | 356 | 0.360 |
Why?
|
| Neurosurgery | 2 | 2018 | 37 | 0.350 |
Why?
|
| Mouth | 1 | 2010 | 25 | 0.350 |
Why?
|
| Occipital Bone | 1 | 2010 | 18 | 0.350 |
Why?
|
| Glioblastoma | 1 | 2011 | 156 | 0.350 |
Why?
|
| Bone Neoplasms | 1 | 2011 | 111 | 0.350 |
Why?
|
| Female | 20 | 2019 | 19959 | 0.350 |
Why?
|
| Middle Aged | 15 | 2019 | 11817 | 0.350 |
Why?
|
| Neuroendoscopes | 1 | 2009 | 1 | 0.340 |
Why?
|
| Neuroendoscopy | 1 | 2009 | 4 | 0.340 |
Why?
|
| Ependymoma | 1 | 2009 | 4 | 0.330 |
Why?
|
| Joint Instability | 1 | 2010 | 76 | 0.330 |
Why?
|
| Diskectomy | 3 | 2015 | 14 | 0.330 |
Why?
|
| Vertebroplasty | 1 | 2008 | 1 | 0.310 |
Why?
|
| Polymethyl Methacrylate | 1 | 2008 | 13 | 0.310 |
Why?
|
| Aneurysm, Dissecting | 1 | 2008 | 12 | 0.300 |
Why?
|
| Intracranial Aneurysm | 1 | 2008 | 68 | 0.280 |
Why?
|
| Renal Artery | 1 | 2006 | 47 | 0.270 |
Why?
|
| Renal Artery Obstruction | 1 | 2006 | 41 | 0.270 |
Why?
|
| Abdominal Injuries | 1 | 2006 | 31 | 0.270 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 458 | 0.260 |
Why?
|
| Gliosarcoma | 1 | 2005 | 1 | 0.260 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2006 | 88 | 0.260 |
Why?
|
| Postoperative Complications | 5 | 2015 | 780 | 0.250 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 190 | 0.250 |
Why?
|
| Stents | 1 | 2006 | 177 | 0.250 |
Why?
|
| Aged | 12 | 2019 | 10301 | 0.240 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 104 | 0.240 |
Why?
|
| Brain Neoplasms | 2 | 2010 | 638 | 0.230 |
Why?
|
| Spinal Diseases | 2 | 2014 | 16 | 0.210 |
Why?
|
| Sacrum | 2 | 2014 | 22 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2015 | 1328 | 0.200 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 560 | 0.200 |
Why?
|
| Hematoma, Subdural | 2 | 2013 | 12 | 0.200 |
Why?
|
| Treatment Outcome | 6 | 2013 | 3306 | 0.200 |
Why?
|
| Sarcoma | 2 | 2014 | 73 | 0.200 |
Why?
|
| Signal Transduction | 2 | 2016 | 682 | 0.200 |
Why?
|
| Adult | 7 | 2018 | 9345 | 0.190 |
Why?
|
| Child | 4 | 2013 | 2438 | 0.180 |
Why?
|
| Craniotomy | 2 | 2012 | 46 | 0.180 |
Why?
|
| Radiculopathy | 1 | 2019 | 5 | 0.170 |
Why?
|
| Spinal Stenosis | 1 | 2019 | 10 | 0.170 |
Why?
|
| Brain | 2 | 2006 | 951 | 0.160 |
Why?
|
| Spinal Cord | 2 | 2009 | 130 | 0.160 |
Why?
|
| Spinal Cord Injuries | 2 | 2015 | 39 | 0.150 |
Why?
|
| Hearing Loss | 1 | 2017 | 26 | 0.150 |
Why?
|
| Amphotericin B | 1 | 2017 | 12 | 0.140 |
Why?
|
| Angiography | 2 | 2008 | 80 | 0.140 |
Why?
|
| Antifungal Agents | 1 | 2017 | 40 | 0.140 |
Why?
|
| Protamines | 1 | 2016 | 4 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 61 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2017 | 293 | 0.140 |
Why?
|
| Animals | 6 | 2011 | 7541 | 0.140 |
Why?
|
| Recurrence | 1 | 2017 | 263 | 0.140 |
Why?
|
| Pneumocephalus | 1 | 2015 | 3 | 0.130 |
Why?
|
| Esophageal Perforation | 1 | 2015 | 2 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 3990 | 0.130 |
Why?
|
| Neurologic Examination | 1 | 2015 | 28 | 0.120 |
Why?
|
| DNA | 1 | 2016 | 226 | 0.120 |
Why?
|
| Polymers | 2 | 2005 | 64 | 0.120 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 78 | 0.120 |
Why?
|
| Rats | 2 | 2011 | 1595 | 0.120 |
Why?
|
| Hemipelvectomy | 1 | 2014 | 1 | 0.120 |
Why?
|
| Rhabdomyosarcoma | 1 | 2014 | 6 | 0.120 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2014 | 5 | 0.120 |
Why?
|
| Anticoagulants | 2 | 2013 | 122 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 2265 | 0.120 |
Why?
|
| Neuronavigation | 1 | 2014 | 8 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2014 | 17 | 0.120 |
Why?
|
| Accidents, Traffic | 2 | 2014 | 195 | 0.120 |
Why?
|
| Manikins | 1 | 2014 | 34 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 91 | 0.110 |
Why?
|
| Bone Screws | 1 | 2014 | 57 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 263 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2014 | 111 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2014 | 229 | 0.110 |
Why?
|
| Random Allocation | 2 | 2011 | 226 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2013 | 34 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2014 | 289 | 0.110 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2013 | 39 | 0.110 |
Why?
|
| Cell Movement | 1 | 2014 | 169 | 0.110 |
Why?
|
| Adolescent | 3 | 2010 | 3539 | 0.110 |
Why?
|
| Hematoma, Subdural, Chronic | 1 | 2012 | 3 | 0.110 |
Why?
|
| Young Adult | 4 | 2015 | 2636 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2014 | 508 | 0.100 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 73 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2014 | 833 | 0.100 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2011 | 7 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 36 | 0.100 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 2011 | 4 | 0.100 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 122 | 0.090 |
Why?
|
| Sciatic Neuropathy | 1 | 2011 | 15 | 0.090 |
Why?
|
| Glioma | 1 | 2012 | 136 | 0.090 |
Why?
|
| Tibia | 1 | 2011 | 56 | 0.090 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 10 | 0.090 |
Why?
|
| Retropharyngeal Abscess | 1 | 2010 | 2 | 0.090 |
Why?
|
| Odontoid Process | 1 | 2010 | 2 | 0.090 |
Why?
|
| Internal Fixators | 1 | 2010 | 7 | 0.090 |
Why?
|
| Cell Survival | 1 | 2011 | 284 | 0.090 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 60 | 0.090 |
Why?
|
| Injections, Intraventricular | 2 | 2011 | 13 | 0.090 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2010 | 2 | 0.090 |
Why?
|
| Pharynx | 1 | 2010 | 14 | 0.090 |
Why?
|
| Multiple Trauma | 1 | 2010 | 41 | 0.090 |
Why?
|
| Brachial Plexus | 1 | 2010 | 26 | 0.090 |
Why?
|
| Gene Expression | 1 | 2011 | 338 | 0.090 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2009 | 1 | 0.090 |
Why?
|
| Neoplasms, Bone Tissue | 1 | 2009 | 1 | 0.090 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2009 | 1 | 0.090 |
Why?
|
| Giant Cell Tumors | 1 | 2009 | 4 | 0.080 |
Why?
|
| Radiation Injuries | 1 | 2010 | 76 | 0.080 |
Why?
|
| Hemangioma | 1 | 2009 | 19 | 0.080 |
Why?
|
| Carcinoma | 1 | 2010 | 91 | 0.080 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2009 | 7 | 0.080 |
Why?
|
| Epidural Abscess | 1 | 2009 | 5 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2009 | 59 | 0.080 |
Why?
|
| Radiography | 1 | 2010 | 376 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 58 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2009 | 71 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2009 | 43 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2009 | 76 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2009 | 94 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 86 | 0.080 |
Why?
|
| Delayed-Action Preparations | 2 | 2006 | 34 | 0.080 |
Why?
|
| Disease Management | 1 | 2009 | 126 | 0.080 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2008 | 3 | 0.080 |
Why?
|
| Bone Cements | 1 | 2008 | 11 | 0.080 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 26 | 0.080 |
Why?
|
| Fluoroscopy | 1 | 2008 | 40 | 0.080 |
Why?
|
| Microsurgery | 1 | 2008 | 19 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2014 | 3509 | 0.070 |
Why?
|
| Cerebral Hemorrhage | 1 | 2008 | 68 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 308 | 0.070 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2006 | 1 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 73 | 0.070 |
Why?
|
| Intracranial Embolism | 1 | 2006 | 12 | 0.070 |
Why?
|
| Polyvinyls | 1 | 2006 | 7 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 2006 | 22 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2006 | 27 | 0.070 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 24 | 0.070 |
Why?
|
| Intracranial Hemorrhages | 1 | 2006 | 33 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 407 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2010 | 1269 | 0.070 |
Why?
|
| Hematoma | 1 | 2006 | 27 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2006 | 41 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2006 | 70 | 0.070 |
Why?
|
| Injections, Intralesional | 1 | 2005 | 15 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 2005 | 30 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 66 | 0.060 |
Why?
|
| Microspheres | 1 | 2005 | 44 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 133 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 170 | 0.060 |
Why?
|
| Mice | 1 | 2011 | 2484 | 0.060 |
Why?
|
| Doxorubicin | 1 | 2005 | 82 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2004 | 8 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2006 | 146 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 471 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2004 | 28 | 0.060 |
Why?
|
| Anesthesia, Conduction | 1 | 2004 | 25 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 765 | 0.060 |
Why?
|
| Rabbits | 3 | 2011 | 197 | 0.060 |
Why?
|
| Survival Rate | 1 | 2005 | 877 | 0.050 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 187 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 301 | 0.050 |
Why?
|
| Stroke | 1 | 2008 | 585 | 0.050 |
Why?
|
| Prognosis | 1 | 2006 | 1497 | 0.050 |
Why?
|
| Atrophy | 2 | 2012 | 46 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2004 | 385 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 517 | 0.050 |
Why?
|
| Length of Stay | 2 | 2012 | 314 | 0.040 |
Why?
|
| Leg | 1 | 2019 | 65 | 0.040 |
Why?
|
| Low Back Pain | 1 | 2019 | 45 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 162 | 0.040 |
Why?
|
| Reoperation | 1 | 2019 | 226 | 0.040 |
Why?
|
| Developing Countries | 1 | 2018 | 48 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 472 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2019 | 350 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2014 | 1531 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 663 | 0.040 |
Why?
|
| Pain | 1 | 2019 | 288 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 241 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 83 | 0.030 |
Why?
|
| Automobiles | 1 | 2014 | 15 | 0.030 |
Why?
|
| Air Bags | 1 | 2014 | 15 | 0.030 |
Why?
|
| Neck | 1 | 2014 | 27 | 0.030 |
Why?
|
| Arthroplasty | 1 | 2014 | 29 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 94 | 0.030 |
Why?
|
| Enoxaparin | 1 | 2013 | 20 | 0.030 |
Why?
|
| Warfarin | 1 | 2013 | 29 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 132 | 0.030 |
Why?
|
| Morbidity | 1 | 2013 | 98 | 0.030 |
Why?
|
| Aspirin | 1 | 2013 | 63 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 83 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 27 | 0.030 |
Why?
|
| Pressure | 1 | 2012 | 51 | 0.030 |
Why?
|
| Rotation | 1 | 2012 | 47 | 0.030 |
Why?
|
| Drainage | 1 | 2012 | 72 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2013 | 188 | 0.030 |
Why?
|
| Sacrococcygeal Region | 1 | 2011 | 6 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2011 | 10 | 0.030 |
Why?
|
| Cadaver | 1 | 2012 | 161 | 0.030 |
Why?
|
| Cisterna Magna | 1 | 2011 | 1 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2012 | 58 | 0.020 |
Why?
|
| Survival | 1 | 2011 | 13 | 0.020 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 19 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 64 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2011 | 108 | 0.020 |
Why?
|
| Osteotomy | 1 | 2011 | 51 | 0.020 |
Why?
|
| Tibial Nerve | 1 | 2011 | 22 | 0.020 |
Why?
|
| Anesthesia | 1 | 2011 | 64 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 112 | 0.020 |
Why?
|
| Sural Nerve | 1 | 2011 | 28 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 423 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 259 | 0.020 |
Why?
|
| Executive Function | 1 | 2010 | 57 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2010 | 113 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 71 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2010 | 93 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2009 | 11 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2009 | 42 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2011 | 198 | 0.020 |
Why?
|
| Registries | 1 | 2010 | 298 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2011 | 349 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2010 | 148 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 519 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cerebral Veins | 1 | 2006 | 12 | 0.020 |
Why?
|
| Heart Valves | 1 | 2006 | 16 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2006 | 10 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2006 | 15 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1061 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2006 | 21 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 379 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2006 | 63 | 0.020 |
Why?
|
| Echocardiography | 1 | 2006 | 159 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3876 | 0.020 |
Why?
|
| Drug Implants | 1 | 2004 | 9 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 276 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 97 | 0.010 |
Why?
|
| Analgesia, Epidural | 1 | 2004 | 50 | 0.010 |
Why?
|
| United States | 1 | 2010 | 3939 | 0.010 |
Why?
|